carbonic anhydrase IX inhibitors (Progenics Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecarbonic anhydrase IX inhibitors (Progenics Pharmaceuticals)
Drug Alias Namecarbonic anhydrase IX inhibitors (Molecular Insight)MIP-11267-[99mTc]99mTc3-MIP-126799mTc-MIP-126799mTc-MIP-1436 +[8] 
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive therapeutic agent +[4] 
Mechanisms of ActionCarbonic anhydrase IX inhibitors
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsCarcinoma, Renal CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Insight Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Insight Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal CellNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A